CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0400

Andarine (S-4) Raw

Filed under Raw Materials. The bureau holds 59 laboratory returns for this compound from 22 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

22 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A79.99.910.024 May 202624 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A59.99.910.014 Nov 202516 Apr 2026
Shandong Shengyuan Peptide TechnologyCASE #VI-2026-0634X29.59.39.714 Jan 202524 May 2026
UtherCASE #VI-2026-0902X19.39.39.37 May 20257 May 2025
NextGen HealthCASE #VI-2026-0604X19.09.09.016 Mar 202516 Mar 2025
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A78.97.510.024 May 202624 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A68.76.810.024 May 202624 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A68.56.310.024 May 202624 May 2026
Peptide TechnologiesCASE #VI-2026-0694X18.58.58.58 Jul 20258 Jul 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A38.27.88.824 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A38.07.38.824 May 202624 May 2026
Peptide PartnersCASE #VI-2026-0295X37.35.68.917 Dec 202417 May 2026
Elite Research USACASE #VI-2026-0267X37.25.88.82 Apr 202517 May 2026
PeptiLab ResearchCASE #VI-2026-0267X16.56.56.59 Jun 20259 Jun 2025
M-PeptidesCASE #VI-2026-0442X16.36.36.39 Jun 20259 Jun 2025
Pure RawzCASE #VI-2026-0767X26.05.07.125 Apr 202521 May 2026
Shanghai BaojuCASE #VI-2026-0233X16.06.06.028 Mar 202528 Mar 2025
Platinum CryoCASE #VI-2026-0406X15.55.55.525 Apr 202525 Apr 2025
Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433X14.64.64.613 Feb 202513 Feb 2025
Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498E34.00.96.33 Jun 202517 May 2026
Shaanxi Dideu MedichemCASE #VI-2026-0499X13.93.93.914 Jan 202514 Jan 2025
Explicit SarmsCASE #VI-2026-0017X12.12.12.19 Jun 20259 Jun 2025

Open any subject to view the batch-level evidence for Andarine (S-4) Raw alone.